May 17, 2018 / 9:38 PM / 4 months ago

BRIEF-Kane Biotech Reports Qtrly Loss Per Share (Post Consolidation) $0.011

May 17 (Reuters) - Kane Biotech Inc:

* KANE BIOTECH ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS, GRANTING OF OPTIONS AND INVESTOR RELATIONS IMPROVEMENTS

* KANE BIOTECH INC QTRLY LOSS PER SHARE (POST CONSOLIDATION) $0.011 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below